{"id":"https://openalex.org/W1962270700","doi":"https://doi.org/10.1200/jco.1999.17.3.907","title":"Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer","display_name":"Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W1962270700","doi":"https://doi.org/10.1200/jco.1999.17.3.907","mag":"1962270700","pmid":"https://pubmed.ncbi.nlm.nih.gov/10071283"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1999.17.3.907","doi":"https://doi.org/10.1200/jco.1999.17.3.907","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1999.17.3.907","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1962270700"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110482131","display_name":"Udo J. Vanhoefer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Udo Vanhoefer","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111963859","display_name":"Andreas Harstrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Harstrick","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109060535","display_name":"Claus\u2010Henning K\u00f6hne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claus-Henning K\u00f6hne","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042442230","display_name":"Wolf Achterrath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wolf Achterrath","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113552738","display_name":"Youcef M. Rustum","orcid":"https://orcid.org/0009-0002-7831-3712","observed_orcids":["https://orcid.org/0009-0002-7831-3712"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Youcef M. Rustum","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111640624","display_name":"S. Seeber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siegfried Seeber","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049551730","display_name":"Hansjochen Wilke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hansjochen Wilke","raw_affiliation_strings":["From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Internal Medicine (Cancer Research), West German Cancer Center, University Medical School, Essen, Germany; Department of Hematology and Oncology, Charit\u00e9, Campus Berlin-Buch, Humboldt University, Berlin, Germany; Department of Clinical Research, Oncology-New Technology, Rh\u00f4ne-Poulenc Rorer, Cologne, Germany; and Department of Pharmacology and Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508","https://openalex.org/I39343248","https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.0369,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.9750065,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"17","issue":"3","first_page":"907","last_page":"907"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9359999895095825},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/infusional-fluorouracil","display_name":"infusional fluorouracil","score":0.925000011920929},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.8529999852180481},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/weekly-chemotherapy","display_name":"weekly chemotherapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8479999899864197},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8240000009536743},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7480000257492065},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8949999809265137},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5289999842643738},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6710000038146973},{"id":"https://openalex.org/keywords/treatment-toxicity-management","display_name":"treatment toxicity management","score":0.5120000243186951},{"id":"https://openalex.org/keywords/folfox-regimen","display_name":"FOLFOX regimen","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9300874471664429},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.854662299156189},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7108114361763},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6637777090072632},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6451659798622131},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5765901803970337},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5699819326400757},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5145077705383301},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.462921142578125},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44649824500083923},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38320887088775635}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1999.17.3.907","doi":"https://doi.org/10.1200/jco.1999.17.3.907","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1999.17.3.907","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:10071283","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10071283","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W165178680","https://openalex.org/W181158363","https://openalex.org/W1832060645","https://openalex.org/W1835830368","https://openalex.org/W1855714470","https://openalex.org/W1880102547","https://openalex.org/W1885154202","https://openalex.org/W1897637667","https://openalex.org/W1941365207","https://openalex.org/W1952371628","https://openalex.org/W1973339830","https://openalex.org/W2015829835","https://openalex.org/W2021009641","https://openalex.org/W2038337883","https://openalex.org/W2100198463","https://openalex.org/W2110650955","https://openalex.org/W2129414319","https://openalex.org/W2131508432","https://openalex.org/W2165351839","https://openalex.org/W2179790211","https://openalex.org/W2227311140","https://openalex.org/W2274948752","https://openalex.org/W2332894026","https://openalex.org/W2341601510","https://openalex.org/W2396646859","https://openalex.org/W2546825004","https://openalex.org/W2602544133"],"related_works":["https://openalex.org/W1918961940","https://openalex.org/W2048212105","https://openalex.org/W1958949331","https://openalex.org/W2100651878","https://openalex.org/W2163132108","https://openalex.org/W2018588097","https://openalex.org/W2052350519","https://openalex.org/W1981265379","https://openalex.org/W2011039636"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2],"the":[3,36,57,135,180,204,208,266],"maximum-tolerated":[4],"dose":[5,60,104,139],"(MTD)":[6],"of":[7,11,20,64,77,105,119,146,182,191,200,213,259,271],"a":[8,17,88,248,253],"weekly":[9],"schedule":[10,250],"irinotecan":[12],"(CPT-11),":[13],"leucovorin":[14],"(LV),":[15],"and":[16,30,68,166,172,242],"24-hour":[18],"infusion":[19],"fluorouracil":[21],"(5-FU24h)":[22],"as":[23],"first-line":[24],"chemotherapy":[25],"in":[26,72,125,157,198,269],"advanced":[27],"colorectal":[28,47],"cancer":[29,48],"to":[31,82,93,100,110,142,184,222,261,264],"assess":[32],"preliminary":[33],"data":[34],"on":[35,87,247],"antitumor":[37],"activity.":[38],"PATIENTS":[39],"AND":[40],"METHODS:":[41],"Twenty-six":[42],"patients":[43,159,202,216],"with":[44,74,121,274],"measurable":[45],"metastatic":[46],"were":[49,85,123,132],"entered":[50],"onto":[51],"this":[52],"phase":[53],"I":[54],"study.":[55],"In":[56],"first":[58,136,205],"six":[59,201],"levels,":[61],"fixed":[62],"doses":[63,76,231],"CPT-11":[65,106,122,183,236,260],"(80":[66],"mg/m2)":[67,71],"LV":[69,239],"(500":[70],"combination":[73],"escalated":[75],"5-FU24h":[78,243],"ranging":[79],"from":[80],"1.8":[81],"2.6":[83,244],"g/m2":[84,245],"administered":[86,124],"weekly-times-four":[89],"(dose":[90,97,113,187],"levels":[91,98,140],"1":[92,141],"4)":[94],"or":[95,194],"weekly-times-six":[96,249],"5":[99],"6)":[101],"schedule.":[102],"The":[103,229,257],"was":[107,155,196,210],"then":[108],"increased":[109],"100":[111,185],"mg/m2":[112,186],"level":[114,188],"7).":[115],"RESULTS:":[116],"Seventy-nine":[117],"cycles":[118],"5-FU24h/LV":[120,262],"an":[126,225],"outpatient":[127],"setting.":[128],"No":[129],"dose-limiting":[130],"toxicities":[131],"observed":[133,156,197],"during":[134,203],"cycle":[137],"at":[138],"6,":[143],"but":[144],"diarrhea":[145,190],"grade":[147,177,192],"4":[148],"(National":[149],"Cancer":[150],"Institute":[151],"common":[152],"toxicity":[153],"criteria)":[154],"three":[158],"after":[160],"multiple":[161],"treatment":[162],"cycles.":[163],"Other":[164],"nonhematologic":[165],"hematologic":[167],"side":[168],"effects,":[169],"specifically":[170],"alopecia":[171],"neutropenia,":[173],"did":[174],"not":[175],"exceed":[176],"2.":[178],"With":[179],"escalation":[181],"7),":[189],"3":[193],"higher":[195],"four":[199],"cycle;":[206],"thus,":[207],"MTD":[209],"achieved.":[211],"Sixteen":[212],"25":[214],"response-assessable":[215],"(64%;":[217],"95%":[218],"confidence":[219],"interval,":[220],"45%":[221],"83%)":[223],"achieved":[224],"objective":[226],"response.":[227],"CONCLUSION:":[228],"recommended":[230],"for":[232],"further":[233],"studies":[234],"are":[235],"80":[237],"mg/m2,":[238,241],"500":[240],"given":[246],"followed":[251],"by":[252],"1-week":[254],"rest":[255],"period.":[256],"addition":[258],"seems":[263],"improve":[265],"therapeutic":[267],"efficacy":[268],"terms":[270],"tumor":[272],"response":[273],"manageable":[275],"toxicity.":[276]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1962270700","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
